Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma (Q44317525)

1 December 2017

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma (English)

1 reference

1 December 2017

0 references

1 reference

1 reference

5

1 reference

1 December 2017

3

Joanna S Fowler

1 reference

1 December 2017

1

Nora D Volkow

1 reference

1 December 2017

12

James M Swanson

1 reference

1 December 2017

2

Gene-Jack Wang

1 reference

1 December 2017

8

Yu-Shin Ding

1 reference

1 December 2017

7

Andrew Gifford

1 reference

1 December 2017

10

Naomi R Pappas

1 reference

1 December 2017

Patricia E Molina

4

1 reference

1 December 2017

S John Gatley

series ordinal

6

1 reference

1 December 2017

Christopher Wong

series ordinal

9

1 reference

1 December 2017

Wei Zhu

series ordinal

11

1 reference

1 December 2017

language of work or name

1 reference

13 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

166

1 reference

1 December 2017

3

1 reference

1 December 2017

264-270

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-002-1340-7

1 December 2017

0 references

cites work

Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

The use of psychostimulants in general psychiatry. A reconsideration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

A functional interaction between the mesolimbic dopamine system and vasopressin release in the regulation of blood pressure in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Short-term cardiovascular effects of methylphenidate and adderall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Abuse and toxicity of methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Palliative Uses of Methylphenidate in Patients With Cancer: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Effects of stimulant medication on learning in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Possible novel pharmacodynamic action of cocaine: cardiovascular and behavioral evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Pressor responses to brain dopaminergic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1340-7

Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning

21 January 2018

1 reference

12 December 2020

Practice parameters for the treatment of narcolepsy: an update for 2000.

1 reference

12 December 2020

The Antagonism of Amphetamine-Induced Symptomatology by a Neuroleptic

1 reference

12 December 2020

A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Palliative uses of methylphenidate in patients with cancer: a review.

1 reference

12 December 2020

Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjects

1 reference

12 December 2020

Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine

1 reference

12 December 2020

Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans

1 reference

12 December 2020

Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate.

1 reference

12 December 2020

Intravenous methylphenidate abuse. Prototype for prescription drug abuse

1 reference

12 December 2020

Dopamine and sympathoadrenal activity in man

1 reference

12 December 2020

Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors.

1 reference

12 December 2020

Acute dopaminergic influence on plasma adrenaline levels in the rat

1 reference

12 December 2020

Use of psychostimulants in medically ill patients with neurological disease and major depression

1 reference

12 December 2020

Mesocorticolimbic dopaminergic network: functional and regulatory roles

1 reference

12 December 2020

Cardiovascular responses of hyperactive children to methylphenidate

1 reference

12 December 2020

Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain.

1 reference

12 December 2020

10.1007/S00213-002-1340-7

Identifiers

DOI

1 reference

1 December 2017

1 reference